Compounds Antibody & Antigens (hapten) for drugs abuse residual test

Substances of abuse are chemical that bring changes in behavior, perception, and mood which cause addiction and health complications. Due to the identification and analysis of specific drugs; there are several diagnostic and therapeutic methods for the effective treatment. In this efforts, GeneMedi’s anti-small molecule antibodies and small molecules competitive antigens recoveries show unbounded prospects in intervening on drugs of abuse diagnostics and treatments. These drugs show selective and efficient binding in identifying and counteracting substances of dependance while minimizing harm from such substances on individuals.

Classification-wise, drugs of abuse include opioids, stimulants, Cannabinoids, among others, and each of the mentioned classes has multiple proteins that have various functions as well as different treatment significance. Thus, opioids, for example, include every type of drugs based on opioids, both legal and illegal, such as prescription medications oxycodone, hydrocodone, fentanyl, and heroin. In light of this, GeneMedi’s product can help in the establishment of diagnostic assays that will enable the identification and measurement of opioids. This is true also in the case of treatment of opioid addiction using therapeutic interventions including monoclonal antibodies. Likewise, some prescription drugs like cocaine, methamphetamine, and MDMA can also be identified and attacked with the aid of diagnostic assay made from GeneMedi’s product. Competitive inhibitors can also be synthesised for the purpose of therapeutic intervention on agents that cause stimulant addiction and overdose. Another category of drugs of abuse is cannabinoids that consist of marijuana and synthetic cannabinoids genes, and these are other targets in GeneMedi’s product. Immunotherapy can also be created for cannabinoid addiction and prevention and treatment of overdose situations.

In the drugs of abuse diagnostics and therapeutics, GeneMedi’s anti-small molecule antibodies and small molecules competitive antigens product have great market potential. The possibility of identifying and classifying specific drugs a user takes creates a way of getting at targeted treatments and precision medication. Besides the conventional method of identifying drugs of abuse from different samples, GeneMedi’s product can incorporate several different diagnostic assays such as ELISA, LFIA, colloidal gold IA, CLIA, TINIA, IN, POCT. Therefore, the product imitates the procedure that can change the diagnostic and treatment approach to drug addiction and overdoses, increasing patient’s quality of life.

Q&A

Q1: Drugs of abuse are substances which if taken in the prescribed doses and frequency, can lead to dependency or drug addiction.
A1: Substances that are controlled contain chemicals that cause changes in mood, behaviour and perception leading to dependency and serious health effects.

Q2: How can GeneMedi’s anti-small molecule antibodies and small molecules competitive antigens product transform the management of drug of abuse diagnosis and treatment?
A2: From the present invention, GeneMedi’s biologics show high specificity and efficacy toward drugs of abuse as well as their antagonists that help in reducing such negative impacts on human health. Introducing this product serves as an opportunity to change the situation connected with drug addiction and overload diagnosis and treatment in the future, thus enhancing patient’s quality of life.

Q3: What are the types of drugs of abuse?
A3: Substances of addiction can be divided by opioids, stimulants, cannabinoids and other types, all of which include several proteins that have different role and significance for therapy.

Q4: How can the GeneMedi’s product be utilised in preventing and treating opioid addiction and overdose?
A4: Due to its ability to label bio molecules GeneMedi’s product can be useful in developing diagnostic assays that will enable the identification and measurement of opioids. Similar to other therapeutic inventions like monoclonal antibodies, related inventions can also be produced for the prevention of opioid hunger and opioid overdose.

Q5: To which kind of diagnostic assays can GeneMedi’s anti-small molecule antibodies and small molecules competitive antigens be applied?
A5: In drug of abuse screening, ELISA, LFIA, colloidal gold immunochromatographic assay, CLIA, TINIA, immunonephelometry, and POCT can all be applied to identify the target drugs from various samples with the help of GeneMedi’s product.